#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Laryngeal squamous cell carcinoma Dedifferentiated liposarcoma Congenital megacolon Lupus nephritis Metachromatic leukodystrophy Small for dates baby Chorioretinitis Leber's congenital amaurosis Systemic scleroderma Cystic fibrosis Mitochondrial encephalomyopathy Ependymoma Congenital ectodermal dysplasia Myotonic dystrophy Richter's syndrome More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Diagnostics Cystic fibrosis – Treatment Idiopathic pulmonary fibrosis – Diagnostics Congenital nephrogenic diabetes insipidus – Diagnostics Kearns-Sayre syndrome Primary biliary cholangitis – Diagnostics Haemolytic uraemic syndrome – Treatment Retinoblastoma – Treatment Marginal zone lymphoma refractory Ocular melanoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alrefimotide Idarubicin Ifinatamab Deruxtecan Emedastine Belzutifan Triptorelin Cyclophosphamide Monohydrate Mesalazine Samuraciclib 177Lu-Rhpsma-10.1 Hydralazine Hydrochloride Sulfonamides, Urea Derivatives Lactose Norucholic Acid Skin Autograft MALIC ACID TRV045 Fluoroestradiol F-18 Calcium Folinate Amiodarone Hydrochloride More therapies…

    Learn about Your Condition

    Anal cancer recurrent Cough Caesarean section Thyroid mass Testicular germ cell tumour Small intestine leiomyosarcoma Incontinence Bile acid synthesis disorder Pseudomyxoma peritonei Pulmonary congestion Benign prostatic hyperplasia CADASIL Vitiligo Cognitive disorder Anaplastic thyroid cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Departemental Vendee

Centre Hospitalier Departemental Vendee

Boulevard Stephane Moreau, La Roche sur Yon, 85925, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Nefopam and Sodium Chloride for Pain Relief After Total Hip Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Nefopam
    • Sodium Chloride
    France

  • Study on Amiodarone for Critically Ill Patients After Out-of-Hospital Cardiac Arrest with Shockable Rhythm

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amiodarone Hydrochloride
    France

  • Study Comparing Methotrexate or Leflunomide with Targeted Therapy vs. Methotrexate or Leflunomide with Drug Combination for Rheumatoid Arthritis Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    • Adalimumab
    • Baricitinib
    France

  • Study Comparing FOLFIRINOX and Cisplatin-Etoposide for Patients with Metastatic Gastroenteropancreatic Neuroendocrine Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    Investigated Drugs:
    • Cisplatin
    • Etoposide
    • Fluorouracil
    France

  • Study Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary aspergillosis
    Investigated Drugs:
    • Amphotericine B, Liposome
    • Itraconazole
    • Posaconazole
    France

  • A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Belgium Czechia Denmark France Germany Italy +2

  • Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Carboplatin
    • Codeine Phosphate
    Austria Czechia France Germany Hungary Ireland +4

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma refractory
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Belgium France Germany Italy Portugal

  • Study of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Beclometasone Dipropionate
    France Germany Italy Spain
Previous Page
1 … 7 8 9 10 11 … 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!